GILD
Price
$92.79
Change
+$0.74 (+0.80%)
Updated
Dec 17, 04:59 PM (EDT)
55 days until earnings call
JNJ
Price
$146.39
Change
+$2.54 (+1.77%)
Updated
Dec 17, 04:59 PM (EDT)
35 days until earnings call
Ad is loading...

GILD vs JNJ

Header iconGILD vs JNJ Comparison
Open Charts GILD vs JNJBanner chart's image
Gilead Sciences
Price$92.79
Change+$0.74 (+0.80%)
Volume$102.55K
CapitalizationN/A
Johnson & Johnson
Price$146.39
Change+$2.54 (+1.77%)
Volume$74.61K
CapitalizationN/A
GILD vs JNJ Comparison Chart
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GILD vs. JNJ commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a Buy and JNJ is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (GILD: $92.80 vs. JNJ: $146.41)
Brand notoriety: GILD and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 92% vs. JNJ: 136%
Market capitalization -- GILD: $90.79B vs. JNJ: $380.22B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 1 green FA rating(s).

  • GILD’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 1 green, 4 red.
According to our system of comparison, GILD is a better buy in the long-term than JNJ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 2 TA indicator(s) are bullish while JNJ’s TA Score has 3 bullish TA indicator(s).

  • GILD’s TA Score: 2 bullish, 5 bearish.
  • JNJ’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than GILD.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а +1.34% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -1.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.90%. For the same industry, the average monthly price growth was -3.44%, and the average quarterly price growth was -4.36%.

Reported Earning Dates

GILD is expected to report earnings on Feb 11, 2025.

JNJ is expected to report earnings on Jan 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.90% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than GILD($90.8B). JNJ has higher P/E ratio than GILD: JNJ (30.34) vs GILD (16.20). GILD YTD gains are higher at: 18.271 vs. JNJ (-3.633). JNJ has higher annual earnings (EBITDA): 23.3B vs. GILD (10.5B). JNJ has more cash in the bank: 22.9B vs. GILD (7.26B). GILD has less debt than JNJ: GILD (25B) vs JNJ (29.3B). JNJ has higher revenues than GILD: JNJ (85.2B) vs GILD (27.1B).
GILDJNJGILD / JNJ
Capitalization90.8B380B24%
EBITDA10.5B23.3B45%
Gain YTD18.271-3.633-503%
P/E Ratio16.2030.3453%
Revenue27.1B85.2B32%
Total Cash7.26B22.9B32%
Total Debt25B29.3B85%
FUNDAMENTALS RATINGS
GILD vs JNJ: Fundamental Ratings
GILD
JNJ
OUTLOOK RATING
1..100
2055
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
1745
SMR RATING
1..100
3947
PRICE GROWTH RATING
1..100
4360
P/E GROWTH RATING
1..100
182
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (15) in the Pharmaceuticals Major industry is significantly better than the same rating for GILD (91) in the Biotechnology industry. This means that JNJ’s stock grew significantly faster than GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (17) in the Biotechnology industry is in the same range as JNJ (45) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

GILD's SMR Rating (39) in the Biotechnology industry is in the same range as JNJ (47) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

GILD's Price Growth Rating (43) in the Biotechnology industry is in the same range as JNJ (60) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

GILD's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for JNJ (82) in the Pharmaceuticals Major industry. This means that GILD’s stock grew significantly faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GILDJNJ
RSI
ODDS (%)
Bearish Trend 6 days ago
55%
Bullish Trend 3 days ago
49%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
50%
Momentum
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
41%
MACD
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
57%
Bearish Trend 3 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
50%
Bearish Trend 7 days ago
44%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
Bullish Trend 3 days ago
45%
Bearish Trend 3 days ago
35%
View a ticker or compare two or three
Ad is loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA463.0226.79
+6.14%
Tesla
GME29.441.45
+5.18%
GameStop Corp
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with JNJ. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.21%
JNJ - GILD
34%
Loosely correlated
-1.89%
BMY - GILD
32%
Poorly correlated
+0.16%
AMGN - GILD
26%
Poorly correlated
-1.52%
AZN - GILD
23%
Poorly correlated
-0.53%
MRK - GILD
21%
Poorly correlated
-1.12%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+1.78%
PFE - JNJ
46%
Loosely correlated
+4.67%
BMY - JNJ
38%
Loosely correlated
+3.19%
MRK - JNJ
37%
Loosely correlated
N/A
ABBV - JNJ
36%
Loosely correlated
+2.18%
GILD - JNJ
34%
Loosely correlated
+0.81%
More